ANDA 71659, held by Superpharm. Flurazepam Hydrochloride.
As of Nov 16, 2026, ANDA 71659 (Flurazepam Hydrochloride), held by Superpharm, was not approved, with 1 approved supplement and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Flurazepam Hydrochloride15MG ยท capsule;oral | Flurazepam Hydrochloride | Discontinued |
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 6, 1989 | Supplement 2Labeling | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters